Miami, FL / Global — March 22nd, 2026
Global Stem Cells Group, operating under RMTG, today announced the official launch of the ISSCA Mobile App, a next-generation digital platform designed to unify physician education, clinical collaboration, and professional networking across the rapidly growing regenerative and longevity medicine sectors.
The app has been developed by ISSCA (International Society for Stem Cell Application), the Company’s education and training division, and represents a strategic move toward building the digital infrastructure layer of regenerative medicine globally.
A Strategic Shift Toward Platform-Based Medicine
With this launch, Global Stem Cells Group transitions beyond traditional clinical services and training into a technology-enabled ecosystem model, connecting physicians, education, and clinical innovation through a centralized digital platform.
The ISSCA App enables physicians worldwide to:
- Access on-demand regenerative medicine training and protocols
- Participate in live and recorded global webinars
- Track certifications and professional credentials
- Engage in physician-only collaboration forums
- Stay connected to ISSCA events, summits, and certification programs
This positions the Company to expand its role from a service provider into a scalable digital platform company within the healthcare and biotechnology sector.
Expanding a Global Physician Network
Global Stem Cells Group operates internationally through its subsidiary network, providing regenerative medicine solutions, physician training, and clinical services across multiple regions.
Through ISSCA, the Company has built a global physician ecosystem spanning more than 30 countries, combining education, clinical protocols, and product distribution into a unified model.
The ISSCA App now digitizes and scales this network, allowing for continuous engagement rather than episodic interaction through conferences and in-person training.
Industry Context: Digital Transformation of Medical Education
The launch comes amid a broader transformation in healthcare, where:
- Physicians increasingly demand on-demand, mobile-first education
- Clinical knowledge is evolving rapidly, especially in regenerative and longevity medicine
- Digital communities are replacing traditional, fragmented learning models
By consolidating education, certification, and networking into a single platform, the ISSCA App addresses a critical gap in the market:
continuous, real-time access to evolving medical knowledge and peer collaboration.
Executive Commentary
Benito Novas, CEO of Global Stem Cells Group, commented:
“The future of medicine is not only biological—it is connected. With the ISSCA App, we are creating a global digital network where physicians can learn, collaborate, and evolve in real time. This is a foundational step toward building the infrastructure of next-generation medicine.”
Competitive Positioning
The ISSCA App differentiates itself through:
- A specialized focus on regenerative and longevity medicine
- Integration of education, certification, and networking into one platform
- Direct access to global experts and real-world clinical protocols
- A scalable model designed to support thousands of physicians globally
This positions Global Stem Cells Group as one of the few companies combining:
- Clinical services
- Physician education
- Biologic product commercialization
- Digital platform infrastructure
Strategic Synergy with ISSCA AI™
The ISSCA App also lays the groundwork for integration with ISSCA AI™, the Company’s clinical intelligence platform.
Together, these technologies will enable a unified ecosystem where physicians can:
- Learn through the ISSCA App
- Connect and collaborate globally
- Optimize clinical decisions using AI-driven tools
This convergence represents a key step toward building a fully integrated, AI-powered regenerative medicine network.
Market Opportunity
Global Stem Cells Group operates within a rapidly expanding regenerative medicine and digital health market, driven by:
- Increased adoption of biologics and cellular therapies
- Growing demand for personalized and longevity-focused treatments
- The need for scalable physician education and support systems
The ISSCA App enhances the Company’s ability to:
- Drive physician engagement and retention
- Increase participation in training and certification programs
- Expand its global footprint through digital channels
About Global Stem Cells Group (OTC: RMTG)
Global Stem Cells Group, operating under RMTG, is a regenerative medicine company providing physician training, clinical services, biologics, and turnkey solutions worldwide.
Through its ISSCA division, the Company has established a global network of physicians and continues to expand its footprint across emerging medical markets.
Media & Investor Contact
[sarah Barroso ]Investor Relations: [Info@stemcellsgroup.com ]
Website: www.stemcellsgroup.com
Forward-Looking Statements
This press release contains forward-looking statements regarding future developments, growth, and market opportunities. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected.
